A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-3.23%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$95.5M
AUM Growth
+$95.5M
Cap. Flow
+$4.25M
Cap. Flow %
4.45%
Top 10 Hldgs %
84.86%
Holding
21
New
2
Increased
1
Reduced
Closed
1

Sector Composition

1 Healthcare 87.12%
2 Technology 2.12%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$18.1M 18.96% 1,301,413
TARA icon
2
Protara Therapeutics
TARA
$120M
$16.3M 17.03% 2,017,872
SIEN
3
DELISTED
Sientra, Inc.
SIEN
$14.5M 15.15% 2,199,012
TBRA
4
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$7.38M 7.72% 589,244
CEMP
5
DELISTED
Cempra, Inc.
CEMP
$6.33M 6.63% 383,935
CHMA
6
DELISTED
Chiasma, Inc. Common Stock
CHMA
$6.01M 6.3% 2,080,595
EVAR
7
DELISTED
Lombard Medical, Inc.
EVAR
$3.79M 3.96% 3,473,452
INNL
8
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$3.07M 3.21% 555,555
DRNA
9
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.83M 2.96% 945,757
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
$2.8M 2.93% 1,600,000
CLLS
11
Cellectis
CLLS
$258M
$2.66M 2.78% 100,000
DERM
12
DELISTED
Dermira, Inc.
DERM
$2.05M 2.14% 70,000
ADAP
13
Adaptimmune Therapeutics
ADAP
$15.6M
$2.03M 2.13% 250,000
SENS icon
14
Senseonics Holdings
SENS
$374M
$2.03M 2.12% +516,882 New +$2.03M
IMDZ
15
DELISTED
Immune Design Corp.
IMDZ
$1.61M 1.69% +197,300 New +$1.61M
AUPH icon
16
Aurinia Pharmaceuticals
AUPH
$1.58B
$1.39M 1.45% 512,036 +423,729 +480% +$1.15M
ANTH
17
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.35M 1.41% 437,994
RGLS
18
DELISTED
Regulus Therapeutics
RGLS
$943K 0.99% 327,350
ACHV icon
19
Achieve Life Sciences
ACHV
$152M
$400K 0.42% 396,104
EPRS
20
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$4K ﹤0.01% 7,896
CCXI
21
DELISTED
ChemoCentryx, Inc.
CCXI
-215,000 Closed -$533K